Mukund Paravasthu's most recent trade in NovoCure Ltd was a trade of 592 Ordinary Shares done at an average price of $17.9 . Disclosure was reported to the exchange on May 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.91 per share. | 03 May 2025 | 592 | 83,556 (0%) | 0% | 17.9 | 10,604 | Ordinary Shares |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 84,148 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.54 per share. | 03 Mar 2025 | 250 | 29,173 (0%) | 0% | 18.5 | 4,634 | Ordinary Shares |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.92 per share. | 27 Feb 2025 | 1,379 | 30,058 (0%) | 0% | 19.9 | 27,472 | Ordinary Shares |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.29 per share. | 27 Feb 2025 | 368 | 29,423 (0%) | 0% | 18.3 | 6,729 | Ordinary Shares |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.55 per share. | 27 Feb 2025 | 267 | 29,791 (0%) | 0% | 20.6 | 5,487 | Ordinary Shares |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 26.81 per share. | 11 Jan 2025 | 2,160 | 31,437 (0%) | 0% | 26.8 | 57,906 | Ordinary Shares |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2024 | 45,620 | 45,620 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2024 | 30,138 | 33,597 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.68 per share. | 02 Nov 2024 | 44 | 3,459 (0%) | 0% | 16.7 | 734 | Ordinary Shares |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.88 per share. | 01 Nov 2024 | 160 | 3,503 (0%) | 0% | 15.9 | 2,540 | Ordinary Shares |